COMMUNIQUÉS West-GlobeNewswire

Emergent BioSolutions Announces Exercise by BARDA of the First Contract Option, Valued at $261 Million, to Procure Doses of AV7909 Anthrax Vaccine Candidate for the Strategic National Stockpile

30/07/2019 - 22:42

AV7909 next generation vaccine positioned as primary solution for U.S. government’s anthrax preparedness and response efforts GAITHERSBURG, Md., July 30, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) [...]

PLx Pharma Inc. to Discuss 2019 Second Quarter Financial Results on August 9, 2019 Conference Call

30/07/2019 - 22:30

HOUSTON, July 30, 2019 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company initially focused on developing its clinically validated and patent- [...]

Opiant Pharmaceuticals to Report Second Quarter 2019 Financial Results and Host Conference Call and Webcast on Thursday, August 8

30/07/2019 - 22:30

SANTA MONICA, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced [...]

Flexion Therapeutics to Report Second-Quarter 2019 Financial Results on August 6, 2019

30/07/2019 - 22:30

BURLINGTON, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its second-quarter 2019 financial results after the close of the U.S. financial markets [...]

Profound Medical to Release Second Quarter 2019 Financial Results on August 14 – Conference Call to Follow

30/07/2019 - 22:30

TORONTO, July 30, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]

Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019

30/07/2019 - 22:30

CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]

Amedisys to Acquire Home Health Regulatory Assets Expanding Access in New York

30/07/2019 - 22:30

BATON ROUGE, La., July 30, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire regulatory [...]

EyePoint Pharmaceuticals Presents Positive Data Showcasing YUTIQ® at the 37th Annual Scientific Meeting of the American Society of Retina Specialists

30/07/2019 - 22:15

WATERTOWN, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]

The Cooper Companies Announces Release Date for Third Quarter 2019

30/07/2019 - 22:15

PLEASANTON, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release third quarter 2019 financial results on Thursday, August 29, 2019, at 4:15 PM ET. Following [...]

Dova Pharmaceuticals to Announce Second Quarter 2019 Financial Results on August 6, 2019

30/07/2019 - 22:15

DURHAM, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Tuesday, August 6, 2019 at 9:00 a.m. ET to discuss second quarter 2019 financial results and [...]

InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6

30/07/2019 - 22:05

Management to host conference call and webcast at 8am ET TEL AVIV, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the [...]

Prothena to Report Second Quarter 2019 Financial Results on August 6

30/07/2019 - 22:05

DUBLIN, Ireland, July 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2019 on [...]

ORYZON Reports Financial Results and Corporate Update for the First Half Ended June 30, 2019

30/07/2019 - 22:05

MADRID, Spain and CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies [...]

BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results

30/07/2019 - 22:05

Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of [...]

Editas Medicine to Host Conference Call Discussing Second Quarter 2019 Results and Corporate Update

30/07/2019 - 22:02

CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, August 6, 2019, at [...]

Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary Endpoint

30/07/2019 - 22:01

ATI-501 achieved statistically significant improvement over placebo in several measures of hair growth, including the primary endpoint and certain secondary endpoints of the trial. ATI-501 was generally well-tolerated [...]

Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2019 Financial and Operating Results

30/07/2019 - 22:01

BOTHELL, Wash., July 30, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock

30/07/2019 - 22:01

CARLSBAD, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today [...]

T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update

30/07/2019 - 22:01

Announces Two Financing Agreements to Potentially Provide up to $60 Million of Additional Capital; Reducing Cash Burn by 30% by Q4 2019 Achieved $1.8 Million in Total Revenue and Secured 12 New T2Dx® Instrument [...]